Display options
Cite
Nkansa-Gyamfi NA, Kazibwe J, Traore DAK, et al. Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal . Glob Health Action. 2019;12:1815272doi: 10.1080/16549716.2020.1815272.
Nkansa-Gyamfi, N. A., Kazibwe, J., Traore, D. A. K., & Nji, E. (2019). Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal . Global health action, 121815272. https://doi.org/10.1080/16549716.2020.1815272
Nkansa-Gyamfi, Nana Adoma, et al. "Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal ." Global health action vol. 12 (2019): 1815272. doi: https://doi.org/10.1080/16549716.2020.1815272
Nkansa-Gyamfi NA, Kazibwe J, Traore DAK, Nji E. Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal . Glob Health Action. 2019 Dec 13;12:1815272. doi: 10.1080/16549716.2020.1815272. PMID: 32909519; PMCID: PMC7782630.
Copy Download .nbib Format: NLM
Share it on

Glob Health Action. 2019 Dec 13;12:1815272. doi: 10.1080/16549716.2020.1815272.

Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal .

Global health action

Nana Adoma Nkansa-Gyamfi, Joseph Kazibwe, Daouda A K Traore, Emmanuel Nji

Affiliations

  1. BioStruct-Africa , Vårby, Sweden.
  2. Department of Infectious Disease Epidemiology, Imperial College London , London, UK.
  3. Faculte ? Des Sciences Et Techniques, Universite ? Des Sciences, Des Techniques Et Des Technologies De Bamako (USTTB) , Bamako, Mali.
  4. Life Sciences Group, Institut Laue- Langevin , Grenoble, France.
  5. School of Life Sciences, Faculty of Natural Sciences, Keele University , Staffordshire, UK.

PMID: 32909519 PMCID: PMC7782630 DOI: 10.1080/16549716.2020.1815272

Abstract

BACKGROUND: The majority of existing studies aimed at investigating the incidence and prevalence of multidrug-resistance by bacteria have been performed in healthcare settings. Relatively few studies have been conducted in community settings, but these have consistently shown a high prevalence of multidrug-resistant bacteria in low- and middle-income countries (LMICs).

OBJECTIVES: To provide an appraisal of the evidence on the high prevalence of multidrug-, extensive drug-, and pandrug-resistance in commensal

METHODS: Using the preferred reporting items for systematic reviews and meta-analyses (PRISMA) guidelines, PubMed, EMBASE, MEDLINE, Web of Science, CINAHL, and Cochrane Library databases were systematically searched with the search string: 'Enterobacteriaceae', OR '

RESULTS: The prevalence of multidrug-, extensive drug- and pandrug-resistance were extracted from articles that met our inclusion criteria and pooled together after a systematic screening of 9,369 items. The prevalence of multidrug-resistance was 28% of 14,336 total cases of isolates tested, 95% CI: 23-32. Extensive drug-resistance was 24% of 8,686 total cases of isolates tested, 95% CI: 14-36. Lastly, pandrug-resistance was 5% of 5,670 total cases of isolates tested, 95% CI: 3-8.

CONCLUSION: This paper provides an appraisal of the evidence on the high prevalence of multidrug-, extensive drug- and pandrug-resistance by commensal

Keywords: Antibiotic resistance; Antimicrobial Resistance; commensal Escherichia coli; community settings; health policy; multidrug resistance

References

  1. Infect Ecol Epidemiol. 2014 Mar 13;4: - PubMed
  2. PLoS One. 2018 Jun 18;13(6):e0199179 - PubMed
  3. Emerg Infect Dis. 2006 Jun;12(6):907-13 - PubMed
  4. Travel Med Infect Dis. 2020 May - Jun;35:101735 - PubMed
  5. Infect Drug Resist. 2018 Oct 10;11:1645-1658 - PubMed
  6. Microb Drug Resist. 2012 Feb;18(1):83-7 - PubMed
  7. Gut. 2016 May;65(5):740-8 - PubMed
  8. PLoS One. 2019 Nov 21;14(11):e0225379 - PubMed
  9. PLoS Med. 2016 Nov 29;13(11):e1002184 - PubMed
  10. Trends Microbiol. 2004 Sep;12(9):412-6 - PubMed
  11. Int J Environ Res Public Health. 2013 Nov 25;10(12):6235-54 - PubMed
  12. Int J Antimicrob Agents. 1996 May;7(1):59-64 - PubMed
  13. BMC Infect Dis. 2013 Oct 14;13:477 - PubMed
  14. BMJ. 2015 Jan 02;350:g7647 - PubMed
  15. Gut. 2016 May;65(5):749-56 - PubMed
  16. J Clin Epidemiol. 2011 Dec;64(12):1294-302 - PubMed
  17. BMJ. 2006 Feb 4;332(7536):248-9 - PubMed
  18. J Appl Microbiol. 2003;95(3):428-36 - PubMed
  19. FEMS Microbiol Lett. 1989 Jun;50(3):275-8 - PubMed
  20. Drug Discov Ther. 2020;14(2):73-76 - PubMed
  21. Cell Host Microbe. 2016 Mar 9;19(3):311-22 - PubMed
  22. Scand J Infect Dis. 2012 Dec;44(12):973-7 - PubMed
  23. Int J Environ Res Public Health. 2017 Apr 06;14(4): - PubMed
  24. Clin Microbiol Infect. 2016 Feb;22(2):178.e1-178.e9 - PubMed
  25. Clin Microbiol Infect. 2012 Mar;18(3):268-81 - PubMed
  26. Epidemiol Infect. 1993 Jun;110(3):447-58 - PubMed
  27. Lancet Infect Dis. 2008 Mar;8(3):159-66 - PubMed
  28. Am Fam Physician. 2001 Mar 15;63(6):1087-98 - PubMed
  29. J Antimicrob Chemother. 2011 Jan;66(1):1-14 - PubMed
  30. Hell J Nucl Med. 2020 Jan-Apr;23(1):4-5 - PubMed
  31. BMJ. 2015 Mar 16;350:h870 - PubMed
  32. New Microbes New Infect. 2015 Apr 16;6:22-9 - PubMed
  33. Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4539-4547 - PubMed
  34. BMC Infect Dis. 2012 Apr 18;12:92 - PubMed
  35. Front Immunol. 2018 Nov 16;9:2640 - PubMed
  36. BMC Infect Dis. 2016 Jul 25;16:359 - PubMed
  37. Glob Health Action. 2019;12(1):1638144 - PubMed
  38. Science. 2016 Apr 29;352(6285):544-5 - PubMed
  39. Microb Drug Resist. 2009 Jun;15(2):103-7 - PubMed
  40. Lancet Glob Health. 2020 May;8(5):e639-e640 - PubMed
  41. Clin Infect Dis. 2020 Dec 3;71(9):2459-2468 - PubMed
  42. Syst Rev. 2016 Dec 5;5(1):210 - PubMed
  43. Lancet Infect Dis. 2019 Jan;19(1):56-66 - PubMed
  44. Lancet Planet Health. 2018 Nov;2(11):e473-e474 - PubMed
  45. Emerg Infect Dis. 2020 Jul;26(7):1478-1488 - PubMed
  46. BMJ Open. 2019 Aug 20;9(8):e028224 - PubMed
  47. J Vet Med Sci. 2017 Mar 18;79(3):479-485 - PubMed
  48. MMWR Recomm Rep. 2016 Nov 11;65(6):1-12 - PubMed
  49. J Infect Dis. 2004 Apr 1;189(7):1291-4 - PubMed
  50. Am J Trop Med Hyg. 2010 May;82(5):879-88 - PubMed
  51. Trop Med Int Health. 1998 Feb;3(2):116-23 - PubMed
  52. Lancet Infect Dis. 2020 May;20(5):531-532 - PubMed
  53. Biochem Pharmacol. 2006 Mar 30;71(7):893-900 - PubMed
  54. J Food Prot. 2007 Feb;70(2):292-9 - PubMed
  55. Int J Environ Res Public Health. 2012 Mar;9(3):746-59 - PubMed
  56. Curr Opin HIV AIDS. 2018 Jan;13(1):73-80 - PubMed
  57. J Infect Dis. 2008 Oct 1;198(7):962-70 - PubMed
  58. Antibiotics (Basel). 2020 Jul 01;9(7): - PubMed

MeSH terms

Publication Types